市場調査レポート

商品コード

1140295

ウイルスクリアランス市場：方法別、用途別、エンドユーザー別：世界の機会分析および産業予測、2021-2031年

Viral clearance Market By Method, By Application, By End User : Global Opportunity Analysis and Industry Forecast, 2021-2031

出版日: 2022年07月01日 | 発行: Allied Market Research

| ページ情報: 英文 288 Pages | 納期: 2～3営業日

価格

PDF (Single User License)

USD 5,730 898,234円

レポートPDFを1つのPCでご利用頂けるライセンスです。ライセンスを付与されたPCでのみレポートPDFの保存、表示、利用が可能です。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は1回だけ可能です。印刷したレポートの利用もPDFのライセンス保持者になります。回覧のための複製も原則NGです。

PDF (5-user License)

USD 6,450 1,011,102円

レポートPDFを5名でご利用頂けるライセンスです。ライセンスを付与されたPCでのみレポートPDFの保存、表示、利用が可能です。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は5回可能です。印刷したレポートの利用もPDFのライセンス保持者5名となります。

PDF (Enterprise User License) & Excel (Data Pack) & Free Update

USD 9,600 1,504,896円

レポートPDFとExcel定量データをひとつの企業、及びその子会社でご利用頂けるライセンスです。ライセンスを付与されたPCでのみレポートPDFとExcelの保存、表示、利用が可能です。PDFとExcel内のテキスト等のコピー＆ペーストは可能です。PDFとExcelの印刷回数の制限はありません。印刷したレポートの利用は企業、及びその子会社内にて共有可能です。無料でレポートのアップデートがご利用いただけます。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=156.76円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

世界のウイルスクリアランス市場は、2021年に4億2593万米ドル、2031年には9億7784万米ドルに達し、2022年から2031年までのCAGRは8.6％と予測されています。

ウイルスクリアランスは、特殊な膜（主にタンパク質）またはクロマトグラフィーを使用してウイルス汚染を除去することです。このようなタンパク質溶液は、ウイルスクリアランスによってウイルス物質を不活性化または除去し、特定の供給源から得られる治療薬がウイルス汚染から完全に取り除かれることを確実にします。

ウイルスクリアランスは、バイオシミラー、抗体、幹細胞製品、バイオ医薬品などの生物製剤の安全性を確保するための製造工程における重要なステップです。医薬品やその他の製品メーカーは、精製・製造プロセスにおいて、ウイルスや伝達性海綿状脳症（TSE）病原体を不活性化または除去する能力を確認し、製品の安全性を保証する必要があります。

市場の成長を促進する主な要因は、バイオテクノロジーおよび製薬企業への投資の増加です。医薬品の上市、研究開発投資の増加、細胞培養の汚染の可能性の上昇、ナノろ過技術の最近の進歩、大きな経済的負担とウイルスクリアランス市場の成長のための巨大な機会を提供すると予測されている慢性疾患の発生率がありました。また、医薬品のアウトソーシングの増加や新興国の市場拡大も、クリアランス市場の成長機会を生み出しています。

しかし、増大し続けるコストと時間のかかる医薬品開発プロセスが、ウイルスクリアランス市場のハードルとなっています。さらに、統合の進展も市場の成長を阻害しています。

ウイルスクリアランス市場は、手法、アプリケーション、エンドユーザー、地域によって区分されます。方法別では、ウイルス除去、ウイルス不活性化に分類されます。ウイルス除去は、さらにクロマトグラフィー、ナノフィルトレーション、沈殿に分類されます。さらに、ウイルス不活性化法は、低pH法、溶剤洗浄法、加熱殺菌法、その他のウイルス不活性化法に分類されます。用途により、組換えタンパク質、血液および血液製剤、細胞および遺伝子治療製品、ワクチン、その他の用途に分類されます。エンドユーザー別では、製薬・バイオテクノロジー企業、受託研究機関、学術研究機関、その他に分類されます。

概要
- 市場規模・予測
ウイルス除去
- 主な市場動向、成長要因、機会
- 市場規模・予測：地域別
- 市場分析：国別
- ウイルス除去のウイルスクリアランス市場：タイプ別
ウイルスの不活性化
- 主な市場動向、成長要因、機会
- 市場規模・予測：地域別
- 市場分析：国別
- ウイルス不活性化ウイルスクリアランス市場：タイプ別

第5章ウイルスクリアランス市場：用途別

概要
- 市場規模・予測
リコンビナントタンパク質
- 主な市場動向、成長要因、機会
- 市場規模・予測：地域別
- 市場分析：国別
血液・血液製剤
- 主要な市場動向、成長要因、機会
- 市場規模・予測：地域別
- 市場分析：国別
細胞・遺伝子治療製品
- 主な市場動向、成長要因、機会
- 市場規模・予測：地域別
- 市場分析：国別
ワクチン
- 主要な市場動向、成長要因、機会
- 市場規模・予測：地域別
- 市場分析：国別
その他の用途
- 主な市場動向、成長要因、機会
- 市場規模・予測：地域別
- 市場分析：国別

第6章ウイルスクリアランス市場：エンドユーザー別

概要
- 市場規模・予測
製薬会社、バイオテクノロジー企業
- 主な市場動向、成長要因と機会
- 市場規模・予測：地域別
- 市場分析：国別
受託研究機関
- 主要な市場動向、成長要因、機会
- 市場規模・予測：地域別
- 市場分析：国別
学術研究機関
- 主な市場動向、成長要因、機会
- 市場規模・予測：地域別
- 市場分析：国別
その他
- 主な市場動向、成長要因、機会
- 市場規模・予測：地域別
- 市場分析：国別

第7章ウイルスクリアランス市場：地域別

概要
- 市場規模・予測
北米
- 主な動向と機会
- 北米の市場規模・予測：方式別
- 北米市場規模・予測：アプリケーション別
- 北米市場規模・予測：エンドユーザー別
- 北米市場規模・予測：国別
  - 米国
  - カナダ
  - メキシコ
欧州
- 主な動向と機会
- 欧州の市場規模・予測：方式別
- 欧州市場規模・予測：アプリケーション別
- 欧州市場規模・予測：エンドユーザー別
- 欧州市場規模・予測：国別
  - ドイツ
  - フランス
  - 英国
  - イタリア
  - スペイン
  - その他の欧州地域
アジア太平洋地域
- 主な動向と機会
- アジア太平洋地域の市場規模・予測：手法別
- アジア太平洋地域の市場規模・予測：アプリケーション別
- アジア太平洋地域の市場規模・予測：エンドユーザー別
- アジア太平洋地域の市場規模・予測：国別
  - 中国
  - 日本
  - インド
  - オーストラリア
  - 韓国
  - その他アジア太平洋地域
LAMEA
- 主な動向と機会
- LAMEAの市場規模・予測：方式別
- LAMEAの市場規模・予測：アプリケーション別
- LAMEAの市場規模・予測：エンドユーザー別
- LAMEAの市場規模・予測：国別
  - ブラジル
  - 南アフリカ共和国
  - サウジアラビア
  - LAMEAの残りの地域

第8章企業情勢

イントロダクション
主要成功戦略
主要10社の製品マッピング
競合ダッシュボード
競合のヒートマップ
主な発展

第9章企業プロファイル

ALLURE MEDICAL GROUP
Charles River Laboratories International, Inc.
CLEAN CELLS
CREATIVE BIOGENE
EUROFINS SCIENTIFIC SE
MARAVAI LIFESCIENCES HOLDINGS, INC.
MERCK KGAA
SARTORIUS STEDIM BIOTECH
SYNGENE INTERNATIONAL LIMITED
WUXI BIOLOGICS INC.

図表

LIST OF TABLES

TABLE 1. GLOBAL VIRAL CLEARANCE MARKET, BY METHOD, 2021-2031 ($MILLION)
TABLE 2. VIRAL CLEARANCE MARKET SIZE, FOR VIRAL REMOVAL, BY REGION, 2021-2031 ($MILLION)
TABLE 3. VIRAL CLEARANCE MARKET FOR VIRAL REMOVAL, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 4. GLOBAL VIRAL REMOVAL VIRAL CLEARANCE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 5. VIRAL CLEARANCE MARKET SIZE, FOR VIRAL INACTIVATION, BY REGION, 2021-2031 ($MILLION)
TABLE 6. VIRAL CLEARANCE MARKET FOR VIRAL INACTIVATION, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 7. GLOBAL VIRAL INACTIVATION VIRAL CLEARANCE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 8. GLOBAL VIRAL CLEARANCE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 9. VIRAL CLEARANCE MARKET SIZE, FOR RECOMBINANT PROTEINS, BY REGION, 2021-2031 ($MILLION)
TABLE 10. VIRAL CLEARANCE MARKET FOR RECOMBINANT PROTEINS, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 11. VIRAL CLEARANCE MARKET SIZE, FOR BLOOD AND BLOOD PRODUCTS, BY REGION, 2021-2031 ($MILLION)
TABLE 12. VIRAL CLEARANCE MARKET FOR BLOOD AND BLOOD PRODUCTS, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 13. VIRAL CLEARANCE MARKET SIZE, FOR CELLULAR AND GENE THERAPY PRODUCTS, BY REGION, 2021-2031 ($MILLION)
TABLE 14. VIRAL CLEARANCE MARKET FOR CELLULAR AND GENE THERAPY PRODUCTS, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 15. VIRAL CLEARANCE MARKET SIZE, FOR VACCINE, BY REGION, 2021-2031 ($MILLION)
TABLE 16. VIRAL CLEARANCE MARKET FOR VACCINE, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 17. VIRAL CLEARANCE MARKET SIZE, FOR OTHER APPLICATIONS, BY REGION, 2021-2031 ($MILLION)
TABLE 18. VIRAL CLEARANCE MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 19. GLOBAL VIRAL CLEARANCE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 20. VIRAL CLEARANCE MARKET SIZE, FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2021-2031 ($MILLION)
TABLE 21. VIRAL CLEARANCE MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 22. VIRAL CLEARANCE MARKET SIZE, FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2021-2031 ($MILLION)
TABLE 23. VIRAL CLEARANCE MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 24. VIRAL CLEARANCE MARKET SIZE, FOR ACADEMIC RESEARCH INSTITUTES, BY REGION, 2021-2031 ($MILLION)
TABLE 25. VIRAL CLEARANCE MARKET FOR ACADEMIC RESEARCH INSTITUTES, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 26. VIRAL CLEARANCE MARKET SIZE, FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
TABLE 27. VIRAL CLEARANCE MARKET FOR OTHERS, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 28. VIRAL CLEARANCE MARKET, BY REGION, 2021-2031 ($MILLION)
TABLE 29. NORTH AMERICA VIRAL CLEARANCE MARKET, BY METHOD, 2021-2031 ($MILLION)
TABLE 30. NORTH AMERICA VIRAL CLEARANCE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 31. NORTH AMERICA VIRAL CLEARANCE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 32. NORTH AMERICA VIRAL CLEARANCE MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 33. U.S. VIRAL CLEARANCE MARKET, BY METHOD, 2021-2031 ($MILLION)
TABLE 34. U.S. VIRAL CLEARANCE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 35. U.S. VIRAL CLEARANCE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 36. CANADA VIRAL CLEARANCE MARKET, BY METHOD, 2021-2031 ($MILLION)
TABLE 37. CANADA VIRAL CLEARANCE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 38. CANADA VIRAL CLEARANCE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 39. MEXICO VIRAL CLEARANCE MARKET, BY METHOD, 2021-2031 ($MILLION)
TABLE 40. MEXICO VIRAL CLEARANCE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 41. MEXICO VIRAL CLEARANCE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 42. EUROPE VIRAL CLEARANCE MARKET, BY METHOD, 2021-2031 ($MILLION)
TABLE 43. EUROPE VIRAL CLEARANCE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 44. EUROPE VIRAL CLEARANCE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 45. EUROPE VIRAL CLEARANCE MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 46. GERMANY VIRAL CLEARANCE MARKET, BY METHOD, 2021-2031 ($MILLION)
TABLE 47. GERMANY VIRAL CLEARANCE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 48. GERMANY VIRAL CLEARANCE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 49. FRANCE VIRAL CLEARANCE MARKET, BY METHOD, 2021-2031 ($MILLION)
TABLE 50. FRANCE VIRAL CLEARANCE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 51. FRANCE VIRAL CLEARANCE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 52. UK VIRAL CLEARANCE MARKET, BY METHOD, 2021-2031 ($MILLION)
TABLE 53. UK VIRAL CLEARANCE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 54. UK VIRAL CLEARANCE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 55. ITALY VIRAL CLEARANCE MARKET, BY METHOD, 2021-2031 ($MILLION)
TABLE 56. ITALY VIRAL CLEARANCE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 57. ITALY VIRAL CLEARANCE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 58. SPAIN VIRAL CLEARANCE MARKET, BY METHOD, 2021-2031 ($MILLION)
TABLE 59. SPAIN VIRAL CLEARANCE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 60. SPAIN VIRAL CLEARANCE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 61. REST OF EUROPE VIRAL CLEARANCE MARKET, BY METHOD, 2021-2031 ($MILLION)
TABLE 62. REST OF EUROPE VIRAL CLEARANCE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 63. REST OF EUROPE VIRAL CLEARANCE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 64. ASIA-PACIFIC VIRAL CLEARANCE MARKET, BY METHOD, 2021-2031 ($MILLION)
TABLE 65. ASIA-PACIFIC VIRAL CLEARANCE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 66. ASIA-PACIFIC VIRAL CLEARANCE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 67. ASIA-PACIFIC VIRAL CLEARANCE MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 68. CHINA VIRAL CLEARANCE MARKET, BY METHOD, 2021-2031 ($MILLION)
TABLE 69. CHINA VIRAL CLEARANCE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 70. CHINA VIRAL CLEARANCE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 71. JAPAN VIRAL CLEARANCE MARKET, BY METHOD, 2021-2031 ($MILLION)
TABLE 72. JAPAN VIRAL CLEARANCE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 73. JAPAN VIRAL CLEARANCE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 74. INDIA VIRAL CLEARANCE MARKET, BY METHOD, 2021-2031 ($MILLION)
TABLE 75. INDIA VIRAL CLEARANCE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 76. INDIA VIRAL CLEARANCE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 77. AUSTRALIA VIRAL CLEARANCE MARKET, BY METHOD, 2021-2031 ($MILLION)
TABLE 78. AUSTRALIA VIRAL CLEARANCE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 79. AUSTRALIA VIRAL CLEARANCE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 80. SOUTH KOREA VIRAL CLEARANCE MARKET, BY METHOD, 2021-2031 ($MILLION)
TABLE 81. SOUTH KOREA VIRAL CLEARANCE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 82. SOUTH KOREA VIRAL CLEARANCE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 83. REST OF ASIA-PACIFIC VIRAL CLEARANCE MARKET, BY METHOD, 2021-2031 ($MILLION)
TABLE 84. REST OF ASIA-PACIFIC VIRAL CLEARANCE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 85. REST OF ASIA-PACIFIC VIRAL CLEARANCE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 86. LAMEA VIRAL CLEARANCE MARKET, BY METHOD, 2021-2031 ($MILLION)
TABLE 87. LAMEA VIRAL CLEARANCE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 88. LAMEA VIRAL CLEARANCE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 89. LAMEA VIRAL CLEARANCE MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 90. BRAZIL VIRAL CLEARANCE MARKET, BY METHOD, 2021-2031 ($MILLION)
TABLE 91. BRAZIL VIRAL CLEARANCE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 92. BRAZIL VIRAL CLEARANCE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 93. SOUTH AFRICA VIRAL CLEARANCE MARKET, BY METHOD, 2021-2031 ($MILLION)
TABLE 94. SOUTH AFRICA VIRAL CLEARANCE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 95. SOUTH AFRICA VIRAL CLEARANCE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 96. SAUDI ARABIA VIRAL CLEARANCE MARKET, BY METHOD, 2021-2031 ($MILLION)
TABLE 97. SAUDI ARABIA VIRAL CLEARANCE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 98. SAUDI ARABIA VIRAL CLEARANCE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 99. REST OF LAMEA VIRAL CLEARANCE MARKET, BY METHOD, 2021-2031 ($MILLION)
TABLE 100. REST OF LAMEA VIRAL CLEARANCE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 101. REST OF LAMEA VIRAL CLEARANCE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 102.ALLURE MEDICAL GROUP: COMPANY SNAPSHOT
TABLE 103.ALLURE MEDICAL GROUP: OPERATING SEGMENTS
TABLE 104.ALLURE MEDICAL GROUP: PRODUCT PORTFOLIO
TABLE 105.ALLURE MEDICAL GROUP: NET SALES,
TABLE 106.ALLURE MEDICAL GROUP: KEY STRATERGIES
TABLE 107.CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: COMPANY SNAPSHOT
TABLE 108.CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: OPERATING SEGMENTS
TABLE 109.CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: PRODUCT PORTFOLIO
TABLE 110.CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: NET SALES,
TABLE 111.CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: KEY STRATERGIES
TABLE 112.CLEAN CELLS: COMPANY SNAPSHOT
TABLE 113.CLEAN CELLS: OPERATING SEGMENTS
TABLE 114.CLEAN CELLS: PRODUCT PORTFOLIO
TABLE 115.CLEAN CELLS: NET SALES,
TABLE 116.CLEAN CELLS: KEY STRATERGIES
TABLE 117.CREATIVE BIOGENE: COMPANY SNAPSHOT
TABLE 118.CREATIVE BIOGENE: OPERATING SEGMENTS
TABLE 119.CREATIVE BIOGENE: PRODUCT PORTFOLIO
TABLE 120.CREATIVE BIOGENE: NET SALES,
TABLE 121.CREATIVE BIOGENE: KEY STRATERGIES
TABLE 122.EUROFINS SCIENTIFIC SE: COMPANY SNAPSHOT
TABLE 123.EUROFINS SCIENTIFIC SE: OPERATING SEGMENTS
TABLE 124.EUROFINS SCIENTIFIC SE: PRODUCT PORTFOLIO
TABLE 125.EUROFINS SCIENTIFIC SE: NET SALES,
TABLE 126.EUROFINS SCIENTIFIC SE: KEY STRATERGIES
TABLE 127.MARAVAI LIFESCIENCES HOLDINGS, INC.: COMPANY SNAPSHOT
TABLE 128.MARAVAI LIFESCIENCES HOLDINGS, INC.: OPERATING SEGMENTS
TABLE 129.MARAVAI LIFESCIENCES HOLDINGS, INC.: PRODUCT PORTFOLIO
TABLE 130.MARAVAI LIFESCIENCES HOLDINGS, INC.: NET SALES,
TABLE 131.MARAVAI LIFESCIENCES HOLDINGS, INC.: KEY STRATERGIES
TABLE 132.MERCK KGAA: COMPANY SNAPSHOT
TABLE 133.MERCK KGAA: OPERATING SEGMENTS
TABLE 134.MERCK KGAA: PRODUCT PORTFOLIO
TABLE 135.MERCK KGAA: NET SALES,
TABLE 136.MERCK KGAA: KEY STRATERGIES
TABLE 137.SARTORIUS STEDIM BIOTECH: COMPANY SNAPSHOT
TABLE 138.SARTORIUS STEDIM BIOTECH: OPERATING SEGMENTS
TABLE 139.SARTORIUS STEDIM BIOTECH: PRODUCT PORTFOLIO
TABLE 140.SARTORIUS STEDIM BIOTECH: NET SALES,
TABLE 141.SARTORIUS STEDIM BIOTECH: KEY STRATERGIES
TABLE 142.SYNGENE INTERNATIONAL LIMITED: COMPANY SNAPSHOT
TABLE 143.SYNGENE INTERNATIONAL LIMITED: OPERATING SEGMENTS
TABLE 144.SYNGENE INTERNATIONAL LIMITED: PRODUCT PORTFOLIO
TABLE 145.SYNGENE INTERNATIONAL LIMITED: NET SALES,
TABLE 146.SYNGENE INTERNATIONAL LIMITED: KEY STRATERGIES
TABLE 147.WUXI BIOLOGICS INC.: COMPANY SNAPSHOT
TABLE 148.WUXI BIOLOGICS INC.: OPERATING SEGMENTS
TABLE 149.WUXI BIOLOGICS INC.: PRODUCT PORTFOLIO
TABLE 150.WUXI BIOLOGICS INC.: NET SALES,
TABLE 151.WUXI BIOLOGICS INC.: KEY STRATERGIES

LIST OF FIGURES

FIGURE 1.VIRAL CLEARANCE MARKET SEGMENTATION
FIGURE 2.VIRAL CLEARANCE MARKET,2021-2031
FIGURE 3.VIRAL CLEARANCE MARKET,2021-2031
FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
FIGURE 5.PORTER FIVE-1
FIGURE 6.PORTER FIVE-2
FIGURE 7.PORTER FIVE-3
FIGURE 8.PORTER FIVE-4
FIGURE 9.PORTER FIVE-5
FIGURE 10.TOP PLAYER POSITIONING
FIGURE 11.VIRAL CLEARANCE MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
FIGURE 12.VIRAL CLEARANCE MARKET,BY METHOD,2021(%)
FIGURE 13.COMPARATIVE SHARE ANALYSIS OF VIRAL REMOVAL VIRAL CLEARANCE MARKET,2021-2031(%)
FIGURE 14.COMPARATIVE SHARE ANALYSIS OF VIRAL INACTIVATION VIRAL CLEARANCE MARKET,2021-2031(%)
FIGURE 15.VIRAL CLEARANCE MARKET,BY APPLICATION,2021(%)
FIGURE 16.COMPARATIVE SHARE ANALYSIS OF RECOMBINANT PROTEINS VIRAL CLEARANCE MARKET,2021-2031(%)
FIGURE 17.COMPARATIVE SHARE ANALYSIS OF BLOOD AND BLOOD PRODUCTS VIRAL CLEARANCE MARKET,2021-2031(%)
FIGURE 18.COMPARATIVE SHARE ANALYSIS OF CELLULAR AND GENE THERAPY PRODUCTS VIRAL CLEARANCE MARKET,2021-2031(%)
FIGURE 19.COMPARATIVE SHARE ANALYSIS OF VACCINE VIRAL CLEARANCE MARKET,2021-2031(%)
FIGURE 20.COMPARATIVE SHARE ANALYSIS OF OTHER APPLICATIONS VIRAL CLEARANCE MARKET,2021-2031(%)
FIGURE 21.VIRAL CLEARANCE MARKET,BY END USER,2021(%)
FIGURE 22.COMPARATIVE SHARE ANALYSIS OF PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES VIRAL CLEARANCE MARKET,2021-2031(%)
FIGURE 23.COMPARATIVE SHARE ANALYSIS OF CONTRACT RESEARCH ORGANIZATIONS VIRAL CLEARANCE MARKET,2021-2031(%)
FIGURE 24.COMPARATIVE SHARE ANALYSIS OF ACADEMIC RESEARCH INSTITUTES VIRAL CLEARANCE MARKET,2021-2031(%)
FIGURE 25.COMPARATIVE SHARE ANALYSIS OF OTHERS VIRAL CLEARANCE MARKET,2021-2031(%)
FIGURE 26.VIRAL CLEARANCE MARKET BY REGION,2021
FIGURE 27.U.S. VIRAL CLEARANCE MARKET,2021-2031($MILLION)
FIGURE 28.CANADA VIRAL CLEARANCE MARKET,2021-2031($MILLION)
FIGURE 29.MEXICO VIRAL CLEARANCE MARKET,2021-2031($MILLION)
FIGURE 30.GERMANY VIRAL CLEARANCE MARKET,2021-2031($MILLION)
FIGURE 31.FRANCE VIRAL CLEARANCE MARKET,2021-2031($MILLION)
FIGURE 32.UK VIRAL CLEARANCE MARKET,2021-2031($MILLION)
FIGURE 33.ITALY VIRAL CLEARANCE MARKET,2021-2031($MILLION)
FIGURE 34.SPAIN VIRAL CLEARANCE MARKET,2021-2031($MILLION)
FIGURE 35.REST OF EUROPE VIRAL CLEARANCE MARKET,2021-2031($MILLION)
FIGURE 36.CHINA VIRAL CLEARANCE MARKET,2021-2031($MILLION)
FIGURE 37.JAPAN VIRAL CLEARANCE MARKET,2021-2031($MILLION)
FIGURE 38.INDIA VIRAL CLEARANCE MARKET,2021-2031($MILLION)
FIGURE 39.AUSTRALIA VIRAL CLEARANCE MARKET,2021-2031($MILLION)
FIGURE 40.SOUTH KOREA VIRAL CLEARANCE MARKET,2021-2031($MILLION)
FIGURE 41.REST OF ASIA-PACIFIC VIRAL CLEARANCE MARKET,2021-2031($MILLION)
FIGURE 42.BRAZIL VIRAL CLEARANCE MARKET,2021-2031($MILLION)
FIGURE 43.SOUTH AFRICA VIRAL CLEARANCE MARKET,2021-2031($MILLION)
FIGURE 44.SAUDI ARABIA VIRAL CLEARANCE MARKET,2021-2031($MILLION)
FIGURE 45.REST OF LAMEA VIRAL CLEARANCE MARKET,2021-2031($MILLION)
FIGURE 46. TOP WINNING STRATEGIES, BY YEAR
FIGURE 47. TOP WINNING STRATEGIES, BY DEVELOPMENT
FIGURE 48. TOP WINNING STRATEGIES, BY COMPANY
FIGURE 49.PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 50.COMPETITIVE DASHBOARD
FIGURE 51.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
FIGURE 52.ALLURE MEDICAL GROUP.: NET SALES ,($MILLION)
FIGURE 53.CHARLES RIVER LABORATORIES INTERNATIONAL, INC..: NET SALES ,($MILLION)
FIGURE 54.CLEAN CELLS.: NET SALES ,($MILLION)
FIGURE 55.CREATIVE BIOGENE.: NET SALES ,($MILLION)
FIGURE 56.EUROFINS SCIENTIFIC SE.: NET SALES ,($MILLION)
FIGURE 57.MARAVAI LIFESCIENCES HOLDINGS, INC..: NET SALES ,($MILLION)
FIGURE 58.MERCK KGAA.: NET SALES ,($MILLION)
FIGURE 59.SARTORIUS STEDIM BIOTECH.: NET SALES ,($MILLION)
FIGURE 60.SYNGENE INTERNATIONAL LIMITED.: NET SALES ,($MILLION)
FIGURE 61.WUXI BIOLOGICS INC..: NET SALES ,($MILLION)

Product Code: A17087

The global viral clearance market was valued at $425.93 million in 2021, and is projected to reach $977.84 million by 2031, registering a CAGR of 8.6% from 2022 to 2031.

Viral clearance is the removal of viral contamination using specialized membranes (mostly proteins) or chromatography. These protein solutions undergo viral clearance to inactivate or remove viral materials to ensure that therapeutic drugs derived from certain sources are fully rid of any viral contamination.

Viral clearance is a critical step in the manufacturing process that helps assure the safety of biologics such as biosimilars, antibodies, stem cell products, biopharmaceuticals, and others. Pharmaceutical and other product manufacturers need to be confirmed of its purification and manufacturing processes' capacity to inactivate or eliminate viruses or Transmissible spongiform encephalopathies(TSE) agents, as well as assure product safety.

The key factors that drive the growth of the market are rise in investments in the biotechnology and the pharmaceutical companies. There has been a rise in drug launches, increase in R&D investments, and rise in the possibility of cell culture contamination, recent advancements in nano-filtration technology, large economic burden and incidence of chronic diseases which is projected to provide huge opportunities for the growth of the viral clearance market. Along with this, rise in pharmaceutical outsourcing and increase in emerging markets are creating opportunities for the growth of the viral clearance market.

However, ever increasing cost and time-intensive drug development process are creating hurdles in the viral clearance market. In addition, increased degree of consolidation is also obstructing the growth of the market.

The viral clearance market is segmented on the basis of method, application, end user, and region. By method, it is categorized into viral removal, and viral inactivation. Viral removal is further divided into chromatography, nanofiltration, and precipitation. Viral inactivation is further categorized into low pH, solvent detergent method, heat pasteurization, and other viral inactivation methods. Depending on application, it is classified into recombinant proteins, blood and blood products, cellular and gene therapy products, vaccines, and other applications. By end user, it is categorized into pharmaceutical & biotechnology companies, contract research organizations, academic research institutes, and others.

Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and Rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and Rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and Rest of LAMEA).

North America accounted for the largest market share in the viral clearance market in 2021 and is expected to retain its dominance throughout the forecast period. This is primarily attributed to increase in demand for biopharmaceutical and upsurge in demand for advanced technologies in the purification of recombinant proteins produced by animal cell cultures to create high-value products of modern biotechnology.

The report provides a comprehensive analysis of the key players that operate in the global viral clearance market. The key companies profiled in the report include Allure Medical Group, Charles River Laboratories International, Inc., Clean Cells, Creative Biogene, Eurofins Scientific SE, Maravai Lifesciences Holding, Inc., Merck KGaA, Sartorius Stedium Biotech, Syngene International Limited, and Wuxi Biologics Inc.

Key Benefits For Stakeholders

This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the viral clearance market analysis from 2021 to 2031 to identify the prevailing viral clearance market opportunities.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the viral clearance market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global viral clearance market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Method

Viral Removal
- Type
- Chromatography
- Nanofiltration
- Precipitation
Viral Inactivation
- Type
- Low pH
- Solvent Detergent Method
- Heat Pasteurization
- Other Viral Inactivation Methods

By Application

Recombinant Proteins
Blood and Blood Products
Cellular and Gene Therapy Products
Vaccine
Other Applications

By End User

Pharmaceutical and Biotechnology Companies
Contract Research Organizations
Academic Research Institutes
Others

By Region

North America
- U.S.
- Canada
- Mexico
Europe
- Italy
- Spain
- Germany
- France
- UK
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia-Pacific
LAMEA
- Brazil
- South Africa
- Saudi Arabia
- Rest of LAMEA
Key Market Players
- ALLURE MEDICAL GROUP
- Charles River Laboratories International, Inc.
- CLEAN CELLS
- CREATIVE BIOGENE
- EUROFINS SCIENTIFIC SE
- MARAVAI LIFESCIENCES HOLDINGS, INC.
- MERCK KGAA
- SARTORIUS STEDIM BIOTECH
- SYNGENE INTERNATIONAL LIMITED
- WUXI BIOLOGICS INC.

CHAPTER 1:INTRODUCTION

1.1.Report description
1.2.Key market segments
1.3.Key benefits to the stakeholders
1.4.Research Methodology
- 1.4.1.Secondary research
- 1.4.2.Primary research
- 1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

2.1.Key findings of the study
2.2.CXO Perspective

CHAPTER 3:MARKET OVERVIEW

3.1.Market definition and scope
3.2.Key findings
- 3.2.1.Top investment pockets
3.3.Porter's five forces analysis
3.4.Top player positioning
3.5.Market dynamics
- 3.5.1.Drivers
- 3.5.2.Restraints
- 3.5.3.Opportunities
3.6.COVID-19 Impact Analysis on the market

CHAPTER 4: VIRAL CLEARANCE MARKET, BY METHOD

4.1 Overview
- 4.1.1 Market size and forecast
4.2 Viral Removal
- 4.2.1 Key market trends, growth factors and opportunities
- 4.2.2 Market size and forecast, by region
- 4.2.3 Market analysis by country
- 4.2.4 Viral Removal Viral clearance Market by Type
4.3 Viral Inactivation
- 4.3.1 Key market trends, growth factors and opportunities
- 4.3.2 Market size and forecast, by region
- 4.3.3 Market analysis by country
- 4.3.4 Viral Inactivation Viral clearance Market by Type

CHAPTER 5: VIRAL CLEARANCE MARKET, BY APPLICATION

5.1 Overview
- 5.1.1 Market size and forecast
5.2 Recombinant Proteins
- 5.2.1 Key market trends, growth factors and opportunities
- 5.2.2 Market size and forecast, by region
- 5.2.3 Market analysis by country
5.3 Blood and Blood Products
- 5.3.1 Key market trends, growth factors and opportunities
- 5.3.2 Market size and forecast, by region
- 5.3.3 Market analysis by country
5.4 Cellular and Gene Therapy Products
- 5.4.1 Key market trends, growth factors and opportunities
- 5.4.2 Market size and forecast, by region
- 5.4.3 Market analysis by country
5.5 Vaccine
- 5.5.1 Key market trends, growth factors and opportunities
- 5.5.2 Market size and forecast, by region
- 5.5.3 Market analysis by country
5.6 Other Applications
- 5.6.1 Key market trends, growth factors and opportunities
- 5.6.2 Market size and forecast, by region
- 5.6.3 Market analysis by country

CHAPTER 6: VIRAL CLEARANCE MARKET, BY END USER

6.1 Overview
- 6.1.1 Market size and forecast
6.2 Pharmaceutical and Biotechnology Companies
- 6.2.1 Key market trends, growth factors and opportunities
- 6.2.2 Market size and forecast, by region
- 6.2.3 Market analysis by country
6.3 Contract Research Organizations
- 6.3.1 Key market trends, growth factors and opportunities
- 6.3.2 Market size and forecast, by region
- 6.3.3 Market analysis by country
6.4 Academic Research Institutes
- 6.4.1 Key market trends, growth factors and opportunities
- 6.4.2 Market size and forecast, by region
- 6.4.3 Market analysis by country
6.5 Others
- 6.5.1 Key market trends, growth factors and opportunities
- 6.5.2 Market size and forecast, by region
- 6.5.3 Market analysis by country

CHAPTER 7: VIRAL CLEARANCE MARKET, BY REGION

7.1 Overview
- 7.1.1 Market size and forecast
7.2 North America
- 7.2.1 Key trends and opportunities
- 7.2.2 North America Market size and forecast, by Method
- 7.2.3 North America Market size and forecast, by Application
- 7.2.4 North America Market size and forecast, by End User
- 7.2.5 North America Market size and forecast, by country
  - 7.2.5.1 U.S.
  - 7.2.5.1.1 Market size and forecast, by Method
  - 7.2.5.1.2 Market size and forecast, by Application
  - 7.2.5.1.3 Market size and forecast, by End User
  - 7.2.5.2 Canada
  - 7.2.5.2.1 Market size and forecast, by Method
  - 7.2.5.2.2 Market size and forecast, by Application
  - 7.2.5.2.3 Market size and forecast, by End User
  - 7.2.5.3 Mexico
  - 7.2.5.3.1 Market size and forecast, by Method
  - 7.2.5.3.2 Market size and forecast, by Application
  - 7.2.5.3.3 Market size and forecast, by End User
7.3 Europe
- 7.3.1 Key trends and opportunities
- 7.3.2 Europe Market size and forecast, by Method
- 7.3.3 Europe Market size and forecast, by Application
- 7.3.4 Europe Market size and forecast, by End User
- 7.3.5 Europe Market size and forecast, by country
  - 7.3.5.1 Germany
  - 7.3.5.1.1 Market size and forecast, by Method
  - 7.3.5.1.2 Market size and forecast, by Application
  - 7.3.5.1.3 Market size and forecast, by End User
  - 7.3.5.2 France
  - 7.3.5.2.1 Market size and forecast, by Method
  - 7.3.5.2.2 Market size and forecast, by Application
  - 7.3.5.2.3 Market size and forecast, by End User
  - 7.3.5.3 UK
  - 7.3.5.3.1 Market size and forecast, by Method
  - 7.3.5.3.2 Market size and forecast, by Application
  - 7.3.5.3.3 Market size and forecast, by End User
  - 7.3.5.4 Italy
  - 7.3.5.4.1 Market size and forecast, by Method
  - 7.3.5.4.2 Market size and forecast, by Application
  - 7.3.5.4.3 Market size and forecast, by End User
  - 7.3.5.5 Spain
  - 7.3.5.5.1 Market size and forecast, by Method
  - 7.3.5.5.2 Market size and forecast, by Application
  - 7.3.5.5.3 Market size and forecast, by End User
  - 7.3.5.6 Rest of Europe
  - 7.3.5.6.1 Market size and forecast, by Method
  - 7.3.5.6.2 Market size and forecast, by Application
  - 7.3.5.6.3 Market size and forecast, by End User
7.4 Asia-Pacific
- 7.4.1 Key trends and opportunities
- 7.4.2 Asia-Pacific Market size and forecast, by Method
- 7.4.3 Asia-Pacific Market size and forecast, by Application
- 7.4.4 Asia-Pacific Market size and forecast, by End User
- 7.4.5 Asia-Pacific Market size and forecast, by country
  - 7.4.5.1 China
  - 7.4.5.1.1 Market size and forecast, by Method
  - 7.4.5.1.2 Market size and forecast, by Application
  - 7.4.5.1.3 Market size and forecast, by End User
  - 7.4.5.2 Japan
  - 7.4.5.2.1 Market size and forecast, by Method
  - 7.4.5.2.2 Market size and forecast, by Application
  - 7.4.5.2.3 Market size and forecast, by End User
  - 7.4.5.3 India
  - 7.4.5.3.1 Market size and forecast, by Method
  - 7.4.5.3.2 Market size and forecast, by Application
  - 7.4.5.3.3 Market size and forecast, by End User
  - 7.4.5.4 Australia
  - 7.4.5.4.1 Market size and forecast, by Method
  - 7.4.5.4.2 Market size and forecast, by Application
  - 7.4.5.4.3 Market size and forecast, by End User
  - 7.4.5.5 South Korea
  - 7.4.5.5.1 Market size and forecast, by Method
  - 7.4.5.5.2 Market size and forecast, by Application
  - 7.4.5.5.3 Market size and forecast, by End User
  - 7.4.5.6 Rest of Asia-Pacific
  - 7.4.5.6.1 Market size and forecast, by Method
  - 7.4.5.6.2 Market size and forecast, by Application
  - 7.4.5.6.3 Market size and forecast, by End User
7.5 LAMEA
- 7.5.1 Key trends and opportunities
- 7.5.2 LAMEA Market size and forecast, by Method
- 7.5.3 LAMEA Market size and forecast, by Application
- 7.5.4 LAMEA Market size and forecast, by End User
- 7.5.5 LAMEA Market size and forecast, by country
  - 7.5.5.1 Brazil
  - 7.5.5.1.1 Market size and forecast, by Method
  - 7.5.5.1.2 Market size and forecast, by Application
  - 7.5.5.1.3 Market size and forecast, by End User
  - 7.5.5.2 South Africa
  - 7.5.5.2.1 Market size and forecast, by Method
  - 7.5.5.2.2 Market size and forecast, by Application
  - 7.5.5.2.3 Market size and forecast, by End User
  - 7.5.5.3 Saudi Arabia
  - 7.5.5.3.1 Market size and forecast, by Method
  - 7.5.5.3.2 Market size and forecast, by Application
  - 7.5.5.3.3 Market size and forecast, by End User
  - 7.5.5.4 Rest of LAMEA
  - 7.5.5.4.1 Market size and forecast, by Method
  - 7.5.5.4.2 Market size and forecast, by Application
  - 7.5.5.4.3 Market size and forecast, by End User

CHAPTER 8: COMPANY LANDSCAPE

8.1. Introduction
8.2. Top winning strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Key developments

CHAPTER 9: COMPANY PROFILES

9.1 ALLURE MEDICAL GROUP
- 9.1.1 Company overview
- 9.1.2 Company snapshot
- 9.1.3 Operating business segments
- 9.1.4 Product portfolio
- 9.1.5 Business performance
- 9.1.6 Key strategic moves and developments
9.2 Charles River Laboratories International, Inc.
- 9.2.1 Company overview
- 9.2.2 Company snapshot
- 9.2.3 Operating business segments
- 9.2.4 Product portfolio
- 9.2.5 Business performance
- 9.2.6 Key strategic moves and developments
9.3 CLEAN CELLS
- 9.3.1 Company overview
- 9.3.2 Company snapshot
- 9.3.3 Operating business segments
- 9.3.4 Product portfolio
- 9.3.5 Business performance
- 9.3.6 Key strategic moves and developments
9.4 CREATIVE BIOGENE
- 9.4.1 Company overview
- 9.4.2 Company snapshot
- 9.4.3 Operating business segments
- 9.4.4 Product portfolio
- 9.4.5 Business performance
- 9.4.6 Key strategic moves and developments
9.5 EUROFINS SCIENTIFIC SE
- 9.5.1 Company overview
- 9.5.2 Company snapshot
- 9.5.3 Operating business segments
- 9.5.4 Product portfolio
- 9.5.5 Business performance
- 9.5.6 Key strategic moves and developments
9.6 MARAVAI LIFESCIENCES HOLDINGS, INC.
- 9.6.1 Company overview
- 9.6.2 Company snapshot
- 9.6.3 Operating business segments
- 9.6.4 Product portfolio
- 9.6.5 Business performance
- 9.6.6 Key strategic moves and developments
9.7 MERCK KGAA
- 9.7.1 Company overview
- 9.7.2 Company snapshot
- 9.7.3 Operating business segments
- 9.7.4 Product portfolio
- 9.7.5 Business performance
- 9.7.6 Key strategic moves and developments
9.8 SARTORIUS STEDIM BIOTECH
- 9.8.1 Company overview
- 9.8.2 Company snapshot
- 9.8.3 Operating business segments
- 9.8.4 Product portfolio
- 9.8.5 Business performance
- 9.8.6 Key strategic moves and developments
9.9 SYNGENE INTERNATIONAL LIMITED
- 9.9.1 Company overview
- 9.9.2 Company snapshot
- 9.9.3 Operating business segments
- 9.9.4 Product portfolio
- 9.9.5 Business performance
- 9.9.6 Key strategic moves and developments
9.10 WUXI BIOLOGICS INC.
- 9.10.1 Company overview
- 9.10.2 Company snapshot
- 9.10.3 Operating business segments
- 9.10.4 Product portfolio
- 9.10.5 Business performance
- 9.10.6 Key strategic moves and developments

ウイルスクリアランス市場：方法別、用途別、エンドユーザー別：世界の機会分析および産業予測、2021-2031年

Viral clearance Market By Method, By Application, By End User : Global Opportunity Analysis and Industry Forecast, 2021-2031

目次

第1章イントロダクション

第2章エグゼクティブサマリー

第3章市場の概要

第4章ウイルスクリアランス市場：手法別

第5章ウイルスクリアランス市場：用途別

第6章ウイルスクリアランス市場：エンドユーザー別

第7章ウイルスクリアランス市場：地域別

第8章企業情勢

第9章企業プロファイル

LIST OF TABLES

LIST OF FIGURES

TABLE OF CONTENTS

CHAPTER 1:INTRODUCTION

CHAPTER 2:EXECUTIVE SUMMARY

CHAPTER 3:MARKET OVERVIEW

CHAPTER 4: VIRAL CLEARANCE MARKET, BY METHOD

CHAPTER 5: VIRAL CLEARANCE MARKET, BY APPLICATION

CHAPTER 6: VIRAL CLEARANCE MARKET, BY END USER

CHAPTER 7: VIRAL CLEARANCE MARKET, BY REGION

CHAPTER 8: COMPANY LANDSCAPE

CHAPTER 9: COMPANY PROFILES

ウイルスクリアランス市場：方法別、用途別、エンドユーザー別：世界の機会分析および産業予測、2021-2031年

Viral clearance Market By Method, By Application, By End User : Global Opportunity Analysis and Industry Forecast, 2021-2031

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 市場の概要

第4章 ウイルスクリアランス市場：手法別

第5章 ウイルスクリアランス市場：用途別

第6章 ウイルスクリアランス市場：エンドユーザー別

第7章 ウイルスクリアランス市場：地域別

第8章 企業情勢

第9章 企業プロファイル

LIST OF TABLES

LIST OF FIGURES

TABLE OF CONTENTS

CHAPTER 1:INTRODUCTION

CHAPTER 2:EXECUTIVE SUMMARY

CHAPTER 3:MARKET OVERVIEW

CHAPTER 4: VIRAL CLEARANCE MARKET, BY METHOD

CHAPTER 5: VIRAL CLEARANCE MARKET, BY APPLICATION

CHAPTER 6: VIRAL CLEARANCE MARKET, BY END USER

CHAPTER 7: VIRAL CLEARANCE MARKET, BY REGION

CHAPTER 8: COMPANY LANDSCAPE

CHAPTER 9: COMPANY PROFILES

第1章イントロダクション

第2章エグゼクティブサマリー

第3章市場の概要

第4章ウイルスクリアランス市場：手法別

第5章ウイルスクリアランス市場：用途別

第6章ウイルスクリアランス市場：エンドユーザー別

第7章ウイルスクリアランス市場：地域別

第8章企業情勢

第9章企業プロファイル